|
From a 2004 source:
"Her1 or HER2 is over-expressed in 30% of primary human breast cancers. These patients show a worse prognosis with overall 50% survival after 90 months compared to 70% with HER2 negative tumors. "
90 months is 7.5 years. And so far no Herceptin in sight for those of us who are between 1 year out and 7.5 years out...
AlaskaAngel
|